Dr. Rosenzweig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Duarte Rd
Duarte, CA 91010Phone+1 626-256-4673Fax+1 626-301-8256
Education & Training
- University of Arizona College of MedicineClass of 2001
Certifications & Licensure
- CA State Medical License 2011 - 2027
- NC State Medical License 2021 - 2022
- NY State Medical License 2009 - 2013
- MA State Medical License 2004 - 2011
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients Start of enrollment: 2022 Mar 07
Roles: Principal Investigator, Contact
- Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis Start of enrollment: 2022 Aug 03
Roles: Contact, Principal Investigator
- Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma Start of enrollment: 2020 Nov 27
Roles: Contact, Principal Investigator
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: